Lv4
780 积分 2023-10-14 加入
Prohibitin is a cholesterol-sensitive regulator of cell cycle transit
23天前
已完结
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer
1个月前
已完结
Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications
2个月前
已完结
Therapies After Progression on Enfortumab Vedotin and Pembrolizumab: Navigating Second-line Options for Metastatic Urothelial Carcinoma in the New Treatment Landscape
2个月前
已完结
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas
2个月前
已完结
Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition
2个月前
已完结
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
2个月前
已完结
When ctDNA says ‘maybe’: improving the dynamics of MRD trials
2个月前
已完结
Endocytic evasion confers resistance to antibody-drug conjugates therapy in cancer
3个月前
已完结
Reversing Bladder Cancer Chemo-resistance through Blocking Cell Senescence by a Combination Therapy
3个月前
已关闭
皖公网安备34019202002308
